← Back to Clinical Trials
Recruiting NCT07122726

Additional Effects of Proprioceptive Neuromuscular Facilitation With Otago Exercises on Fall Risk in Diabetes Mellitus Patients

Trial Parameters

Condition Postural Balance
Sponsor Foundation University Islamabad
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 50 Years
Max Age 75 Years
Start Date 2024-09-13
Completion 2025-12-10
Interventions
Otago and PNF exerciseOtago Exercise

Brief Summary

Diabetes Mellitus is considered as one of the most prevalent issues among global population and 50% of all the diabetic patients particularly diabetes type II develop peripheral neuropathy. Diabetic Peripheral Neuropathy (DPN) affects feet and legs first, followed by the hands and arms. This study will involve two groups, one performing the Otago Exercise Program, and the other performing a combined PNF and Otago exercise protocol. This study aims to assess the additional effects of Proprioceptive Neuromuscular Facilitation with Otago Exercise Program on Risk of fall which will be assessed by assessing balance, Fear of Fall and Sensory Function. Key outcome measures, including the Berg Balance Scale, Fall Efficacy Scale, Functional Reach test and Semmes Weinstein Monofilament Test will be used in evaluating the effectiveness of the exercise interventions. The participants would be screened through Michigan Neuropathy Screening Instrument and Berg Balance scale for inclusion criteria, and outcome measures will be assessed by using Berg Balance Scale, Fall efficacy scale, Functional Reach Test and Semmes Weinstein Monofilament testing method on the day of starting the intervention and on the last day of intervention. Intervention will be given for a total of 40-50 minutes per session, 3 sessions/week for consecutive 6 weeks And than the data will be recorded at the end of 6 weeks again.

Eligibility Criteria

Inclusion Criteria: * Diabetes type 2 patients * 50-75 years of age * Both Males and Female Gender * Duration of diabetes more than 5 years * Participants positive for Michigan Neuropathy Screening Instrument * Patients having berg balance scale score \>20 Exclusion Criteria: * Surgical procedure involving knee, ankle, or hip joints. * Foot Ulcers and Deformities. * Diagnosis of neurological diseases (CVA, MS, Parkinson disease etc.) besides DPN. * Absence of Visual Impairment and Hearing loss Patients having comprehension difficulties * Physical disability that prevents from performing the exercises

Related Trials